清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Prognostic Role of MTAP Loss in Cholangiocarcinoma

内科学 肿瘤科 医学
作者
James A. Lyon,Soravis Osataphan,Vaibhav Birda,Brian Russell,Charly Edmiston,Rodrigo Paredes,Ahmed Rattani,Mary Linton B. Peters
出处
期刊:JCO precision oncology [Lippincott Williams & Wilkins]
卷期号: (9)
标识
DOI:10.1200/po-24-00842
摘要

Methylthioadenosine phosphorylase (MTAP) loss is a common genomic event in cancer and is associated with an immunologically cold phenotype. Recent research has highlighted a synthetic lethality of MTAP loss when combined with PMRT5 or MAT2A inhibition. Although contemporary somatic genomic testing now routinely includes MTAP status, the clinicogenomic characteristics of MTAP loss in cholangiocarcinoma (CCA) remain largely undefined. In this study, we examine the genomic profiles, clinical features, and survival outcomes of MTAP loss CCA. This is a single-center retrospective cohort study of patients with CCA from December 2017 to January 2024. Somatic genomics alterations were assessed using targeted next-generational sequencing with FoundationOne CDx. Patient demographics, tumor characteristics, treatment history, and overall survival (OS) were retrospectively collected. Genomics coalterations were assessed using the Fisher exact test. Multivariate Cox proportional hazards regression analysis was used to assess the relationship between MTAP status and OS. Among 94 CCA samples, 89 were successfully sequenced, uncovering 339 genomic alterations, with MTAP loss identified in 16% of cases. It commonly co-occurred with CDKN2A and B loss (93% and 86%, respectively) and was not associated with FGF2R rearrangement, IDH1 mutation, or human epidermal growth factor receptor 2 (ERBB2) amplification. Tumor mutational burden were similar between MTAP status. MTAP loss was associated with lower OS (hazard ratio, 3.95 [95% CI, 1.43 to 10.9]; P = .008) after adjustment for key covariates including age, Eastern Cooperative Oncology Group performance status, nodal stage, metastatic spread, resectability, histologic, and line of therapy. MTAP loss is common CCA, co-occurred with CDKN2A and CDKN2B loss, and was associated with poor OS. Future effort to exploit this therapeutic vulnerability in MTAP-loss CCA is critical to improve the care of this population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kkdg完成签到,获得积分10
1秒前
大力的映天完成签到,获得积分10
2秒前
独特的又菱完成签到,获得积分10
2秒前
熊熊熊完成签到,获得积分10
3秒前
老实十三完成签到,获得积分10
4秒前
潘润朗完成签到,获得积分10
4秒前
上山打老虎完成签到,获得积分10
4秒前
KKDG完成签到,获得积分10
7秒前
joker000717完成签到,获得积分10
7秒前
July完成签到,获得积分10
8秒前
qimoqi完成签到,获得积分10
11秒前
丁大胜完成签到,获得积分10
11秒前
千帆完成签到,获得积分10
12秒前
敏感盼夏完成签到,获得积分10
12秒前
15秒前
wyl完成签到 ,获得积分10
15秒前
莫忘初心完成签到,获得积分10
16秒前
kaka完成签到,获得积分10
16秒前
129完成签到,获得积分10
16秒前
如歌完成签到,获得积分10
18秒前
205完成签到,获得积分10
21秒前
卡卡完成签到,获得积分10
21秒前
聪明的羿完成签到,获得积分10
21秒前
21秒前
顺心凝阳完成签到,获得积分10
22秒前
shiluodeqiou完成签到,获得积分10
23秒前
白昼完成签到,获得积分10
24秒前
ZHZ完成签到,获得积分10
24秒前
321987杰完成签到 ,获得积分10
26秒前
内向的镜子完成签到,获得积分10
26秒前
MaidLingYan完成签到,获得积分10
26秒前
huan完成签到,获得积分10
29秒前
ssnwlp123完成签到,获得积分10
29秒前
BlueLe完成签到,获得积分10
30秒前
Zilaap完成签到,获得积分10
31秒前
CaptainMus完成签到,获得积分10
32秒前
端庄的如松完成签到,获得积分10
32秒前
皮卡皮卡皮卡丘完成签到,获得积分10
33秒前
Maestro_S的应助被科研通管家采纳,获得10
34秒前
null的应助被科研通管家采纳,获得10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185411
求助须知:如何正确求助?哪些是违规求助? 9574140
关于积分的说明 21834410
捐赠科研通 7782895
什么是DOI,文献DOI怎么找? 3434567
关于科研通互助平台的介绍 2558844
邀请新用户注册赠送积分活动 2481280